Oueslati Morad, Hermosilla Ricardo, Schönenberger Eva, Oorschot Viola, Beyermann Michael, Wiesner Burkhard, Schmidt Antje, Klumperman Judith, Rosenthal Walter, Schülein Ralf
Leibniz-Institut für Molekulare Pharmakologie, Robert-Rössle-Strasse 10, 13125 Berlin, Germany.
J Biol Chem. 2007 Jul 13;282(28):20676-85. doi: 10.1074/jbc.M611530200. Epub 2007 May 8.
Mutant membrane proteins are frequently retained in the early secretory pathway by a quality control system, thereby causing disease. An example are mutants of the vasopressin V(2) receptor (V(2)R) leading to nephrogenic diabetes insipidus. Transport-defective V(2)Rs fall into two classes: those retained exclusively in the endoplasmic reticulum (ER) and those reaching post-ER compartments such as the ER/Golgi intermediate compartment. Although numerous chemical or pharmacological chaperones that rescue the transport of ER-retained membrane proteins are known, substances acting specifically in post-ER compartments have not been described as yet. Using the L62P (ER-retained) and Y205C (reaching post-ER compartments) mutants of the V(2)R as a model, we show here that the cell-penetrating peptide penetratin and its synthetic analog KLAL rescue the transport of the Y205C mutant. In contrast, the location of the L62P mutant is not influenced by either peptide because the peptides are unable to enter the ER. We also show data indicating that the peptide-mediated transport rescue is associated with an increase in cytosolic Ca(2+) concentrations. Thus, we describe a new class of substances influencing protein transport specifically in post-ER compartments.
突变的膜蛋白经常被质量控制系统保留在早期分泌途径中,从而引发疾病。一个例子是加压素V(2)受体(V(2)R)的突变体导致肾性尿崩症。运输缺陷型V(2)R可分为两类:一类仅保留在内质网(ER)中,另一类则到达ER后区室,如ER/高尔基体中间区室。虽然已知有许多化学或药理伴侣可挽救ER保留的膜蛋白的运输,但尚未描述在ER后区室中特异性起作用的物质。以V(2)R的L62P(ER保留型)和Y205C(到达ER后区室型)突变体为模型,我们在此表明细胞穿透肽穿膜肽及其合成类似物KLAL可挽救Y205C突变体的运输。相比之下,L62P突变体的定位不受任何一种肽的影响,因为这些肽无法进入内质网。我们还展示了数据表明肽介导的运输挽救与胞质Ca(2+)浓度的增加有关。因此,我们描述了一类新的物质,它们特异性地影响ER后区室中的蛋白质运输。